1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...

1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...

1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China

1/7/2022Recent Executive Moves

1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...

1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...

1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca

1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...

1/5/2022Review of Sino-Foreign Drug Out-licensing Deals in 2021

1/5/2022Review of Chinese Pharma In-licensing Deals in 2021

1/5/2022SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...

1/5/2022China 2021: The NRDL Readout (PharmExec)

1/4/2022Santhera Enters into Exclusive License Agreement with Sperogenix for V...

1/3/2022Daewoong Submits BTX Product Nabota in China

1/3/2022Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed

1/3/2022Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...

12/30/2021Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...

12/30/2021Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...

12/30/2021NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

12/30/2021NMPA Issues the 14th Five Year Plan for National Drug Safety and Promo...

12/30/2021Financial-related Company News Digest (December 2021)

12/30/2021Recent Executive Moves

12/29/2021Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discu...

12/29/2021CDE Issues the Technical Guidelines for Clinical Single- And Multiple-...

12/29/202118 Promising Novel Drugs Expected to Be Approved in China 2022

12/29/2021Top Ten Chinese Biopharma In-licensing Deals in 2021

12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022

12/27/2021NMPA Announces Rx Switch of OTC Dextromethorphan Hydrobromide Oral Sin...

12/27/2021ITM and Grand Pharma Enter Licensing Deal for Targeted Radiopharmaceut...

12/27/2021Kintor Reports Unsatisfactory Interim Analysis on COVID-19 Pill Trial

Page:78/361 Total number of articles:10811: [First][<<] [76] [77] [78] [79] [80] [>>] [End]